Correction: Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial

Similar Items

• Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial
  od: Zhuang, Qianyu, i dr.
  Izdano: (2020)
• Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial
  od: Zhuang, Qianyu, i dr.
  Izdano: (2016)
• Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib
  od: Tannenbaum, H, i dr.
  Izdano: (2004)
• Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double‐blind, placebo‐controlled study
  od: Mazières, Bernard, i dr.
  Izdano: (2007)
• An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis
  od: Pelletier, Jean-Pierre, i dr.
  Izdano: (2020)